Lactoferrin and interleukin-6 interaction in amniotic infection

Area of Science:

• Obstetrics and Gynecology
• Immunology
• Biochemistry

Background:

• Lactoferrin (Lf), present in biological fluids, has antimicrobial properties and is part of host defense.
• Intrauterine infections can lead to premature labor, often associated with increased prostaglandin production and inflammatory cytokines like IL-6.
• Changes in amniotic fluid lactoferrin concentrations during infection were previously unreported.

Purpose of the Study:

• To measure lactoferrin (Lf) concentrations in amniotic fluid during intrauterine infections.
• To investigate the biological significance of Lf in the context of amniotic infection.
• To examine the effects of Lf on interleukin-6 (IL-6) and IL-6 mRNA production in cultured amnion cells.

Main Methods:

• Measurement of Lf and IL-6 concentrations in amniotic fluid from pregnant women with and without chorioamnionitis (CAM).
• Correlation analysis between Lf and IL-6 levels in amniotic fluid.
• In vitro study using cultured amnion cells to assess the effect of Lf on lipopolysaccharide (LPS)-induced IL-6 production and IL-6 mRNA expression via RT-PCR.

Main Results:

• Significantly higher concentrations of Lf and IL-6 were observed in amniotic fluid from patients with CAM compared to controls.
• A strong positive correlation was found between Lf and IL-6 levels in amniotic fluid.
• Lactoferrin significantly inhibited both IL-6 production and IL-6 mRNA expression in cultured amnion cells stimulated with LPS.

Conclusions:

• Elevated Lf in amniotic fluid during infection suggests a potential role in combating intrauterine infections.
• Lactoferrin may suppress amniotic IL-6 production, indicating a self-defense mechanism against intrauterine microbial invasion.
• Lf's inhibitory effect on IL-6 points to its potential therapeutic significance in managing infection-related pregnancy complications.